imds: Innovative Medical Device Solutions

IMDS acquires Frontier Biomedical

Logan, UT

September 10, 2007

IMDS announced the completion of the acquisition of Frontier Biomedical, Inc., a company that provides comparative medicine research services to the medical device industry. As a result of this acquisition, IMDS is the first orthopedic focused medical device outsourcing company to provide a comprehensive portfolio of services including: product innovation, product development, intellectual property development, comparative medicine research, product supply and supply chain management.

"Frontier Biomedical will provide our OEM partners accelerated time to market for joint development projects that require a research model to demonstrate safety or effectiveness," stated Wade Fallin, President and CEO of IMDS. Fallin continued, "This acquisition further establishes IMDS as the premier outsourcing partner for the medical device OEM's." "Joining the IMDS(Innovative Medical Device Solutions) family will enable Frontier Biomedical to better serve both its large and emerging medical device customers by integrating its services into other select Product Life Cycle SourcingTM services that will optimize our customer's ability to rapidly develop innovative products and get them to market as quickly as possible," stated Raymond Olsen, President of Frontier Biomedical.

About IMDS

IMDS provides comprehensive product development and supply chain management solutions for medical device companies. The IMDS family of companies includes: MedicineLodge, a product development and intellectual property development firm and provider of innovative technology solutions; Frontier Biomedical, a leader in preclinical animal research; and Leis Medical, a world-class, global provider of orthopedic implants and instrumentation.

About Frontier BioMedical, LLC

Frontier BioMedical is a leader in preclinical laboratory animal research. Founded in 1988, the company offers testing services to the medical device industry. Frontier BioMedical has extensive experience with animal models investigating the function and performance of implantable devices, synthetic and biological graft materials, and interventional therapeutics.

In other news